To assess the capacity of spectral confocal microscopy to quantify dystrophin and to prove that this technology is more sensitive than conventional immunofluorescence microscopy, we observed dystrophin IF from muscle samples of patients with DMD, BMD and healthy controls under both types of microscopes. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.